Abstract 169: Preclinical efficacy and sensitivity determinants of evofosfamide in molecularly defined models of head and neck squamous cell carcinoma

Hunter, FrancisShome, AvikLi, DanWong, WayTsai, PPoonawala, NooriyanKakadiya, PurvibahenKetelä, TMKondratyev, MKLynch, CourtneyLee, TetTran, BaoDevaux, JulesZussman, RHong, ChoKee, DMacann, AMHickey, AnthonyBohlander, StefanPrint, CristinWilson, WilliamWouters, BGJamieson, Stephen2018-11-012017-070008-5472http://hdl.handle.net/2292/43778Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htmAbstract 169: Preclinical efficacy and sensitivity determinants of evofosfamide in molecularly defined models of head and neck squamous cell carcinomaJournal Article10.1158/1538-7445.AM2017-169Copyright: The authorhttp://purl.org/eprint/accessRights/RestrictedAccess1538-7445